knowledge -WSS

knowledge

author：comprehensive 2025-09-30 16:05:08 - browse：25

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial.

The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s experimental drug. Treatment with the higher dose of the therapy significantly lowered triglycerides in the blood of those on the drug for six months compared to participants given placebo, though a lower dose did not have this effect. Participants on the high dose didn’t have any instances of painful inflammation of the pancreas, one of the disease’s most serious symptoms, while there were 11 such episodes among those on placebo.

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Reframing the conversation around gain

leisure time

hotspot

WSS

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Astronauts get first look at the spacecraft that will fly them around the moon

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Judge rejects Trump's counterclaim against E. Jean Carroll

EMA weighs against approval for Mirati's lung cancer drug

The biotech scorecard for the 2nd quarter: 12 industry events to watch

leisure time

knowledge

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

New chief aims to remake Sanofi Genzyme

Medicare details structure of new drug price negotiation program

Discs beat pads, tampons for heavy menstrual flow, new study shows

Medical leaders decry Supreme Court decision on affirmative action

Sage's campaign to raise awareness of postpartum depression hits a nerve

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New chart reveals military’s vast involvement in Operation Warp Speed

Heart attack and stroke risk calculators need revising

Germany receives 178 compensation applications from gay servicepeople over discrimination

explore

'The View' co

Biden praises World Series champion Astros for impact off the field during White House celebration

'The View' co

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Biden praises World Series champion Astros for impact off the field during White House celebration

EMA weighs against approval for Mirati's lung cancer drug

leisure time

entertainment

hotspot

entertainment